Growth inhibitor

The present invention relates to a method for producing an insulin-producing cell population or a pancreatic [beta] cell population with reduced Ki67-positive cells, comprising treating a population of endocrine precursor cells or cells in a subsequent differentiation stage with an FGFR1 inhibitor.

Saved in:
Bibliographic Details
Main Authors TOYODA, TARO, YAMAZOE, NORIKO, MOCHIDA, TAISUKE, HIYOSHI, HIDEYUKI, KIMURA, AZUMA, ITO, RYO
Format Patent
LanguageChinese
English
Published 01.12.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method for producing an insulin-producing cell population or a pancreatic [beta] cell population with reduced Ki67-positive cells, comprising treating a population of endocrine precursor cells or cells in a subsequent differentiation stage with an FGFR1 inhibitor.
Bibliography:Application Number: TW20198113987